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MicroRNA-27a regulates beta cardiac myosin heavy chain gene 1 
expression by targeting thyroid hormone receptor 1 in neonatal rat 2 
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MicroRNAs (miRNAs), small non-coding RNAs, are negative regulators of gene 2 
expression and play important roles in gene regulation in the heart. To examine the role of 3 
miRNAs in the expression of the two isoforms of cardiac myosin heavy chain (MHC) gene, 4 
- and -MHC, which regulate cardiac contractility, endogenous miRNAs were 5 
down-regulated in neonatal rat ventricular myocytes (NRVMs) using lentivirus-mediated 6 
siRNA against Dicer, an essential enzyme for miRNA biosynthesis, and MHC expression 7 
levels were examined. As a result, Dicer siRNA could down-regulate endogenous miRNAs 8 
simultaneously, including miR-16 and -133b and the -MHC gene but not -MHC, which 9 
implied that specific miRNAs could up-regulate the -MHC gene. After screening for 10 
-MHC mRNA expression in NRVMs over-expressing of 21 randomly selected miRNAs, 11 
miR-27a was found to up-regulate the -MHC gene but not -MHC. Moreover, -MHC 12 
protein was down-regulated by  silencing of endogenous miR-27a. Through a 13 
bioinformatics screening using TargetScan
TM
, we identified thyroid hormone receptor 1 14 
(TR1), which negatively regulates -MHC transcription, as a target of miR-27a. Moreover, 15 
miR-27a was demonstrated to modulate -MHC gene regulation via thyroid hormone 16 
signaling. These findings suggested that miR-27a regulates -MHC gene expression by 17 






  MicroRNAs (miRNAs) are negative regulators of gene expression that 2 
inhibit the translation or promote the degradation of target mRNAs (36). Mature miRNAs 3 
(10 to 24 nucleotides long) are the result of sequential processing of primary transcripts 4 
(primary miRNAs) mediated by two RNase III enzymes, Drosha and Dicer (6). Recently, it 5 
has been reported that cardiac-specific Dicer-deficient mice presented with cardiac 6 
dysfunction, such as cardiac sudden death, dilated cardiomyopathy and heart failure (4, 7), 7 
suggesting an essential role of the miRNA-processing machinery in the maintenance of 8 
cardiac function. A series of microarray analyses in rodent and human hearts have revealed 9 
the profile of miRNA expression in various pathologic conditions, such as cardiac 10 
hypertrophy, heart failure, and myocardial infarction, which indicated the involvement of 11 
miRNAs in cardiac pathophysiology (5, 27, 29-31, 34, 36). Moreover, genetically modified 12 
mice have revealed the effect of specific miRNAs in the heart. For example, mice lacking 13 
miR-1-2 suffer from cardiac arrhythmia and congenital malformation, and transgenic mice 14 
that over-express miR-195 in the heart or mice lacking miR-133a, a muscle-specific 15 
miRNA, present with cardiac dilatation and heart failure (20, 34, 39). These previous 16 
studies have revealed the novel role of miRNAs in cardiac development and 17 
pathophysiology. 18 
  Cardiac contractility depends on the expression of two cardiac myosin 19 
heavy chain (MHC) genes, - and -MHC, which are regulated in an antithetical manner 20 
by developmental, physiological, and pathological signals (37). Moreover, the -MHC gene 21 
is up-regulated in response to stress signals causing cardiac hypertrophy and heart failure. 22 
 4 
Therefore, a search for factors, including miRNAs, that can regulate -MHC gene 1 
expression may give new findings for heart disease and therapy.  2 
  Recently, two groups have revealed that cardiac specific miR-208a, 3 
encoded by an intron of the -MHC gene, is important for the regulation of-MHC gene 4 
expression using miR-208a-deficient mice and transgenic mice that over-express miR-208a 5 
under control of the -MHC promoter (1, 35). Thus, genetically modified mice are a 6 
powerful tool for elucidating the final outcome derived from specific miRNAs. However, in 7 
vitro screening analyses are still needed to detect the direct effects of individual miRNAs 8 
because neurohormonal and hemodynamic effects are considered to strongly influence the 9 
gene regulation of -MHC among others (24, 26), and possibly blur many direct effects of 10 
miRNAs in vivo. 11 
  Thyroid hormone has a fundamental role in cardiovascular homeostasis in 12 
both physiological and pathological conditions, influencing cardiac contractility, heart rate, 13 
diastolic function, and systemic vascular residence through genomic and non-genomic 14 
effects (11). These multiple effects are largely mediated by the action of nuclear-based 15 
thyroid hormone receptors (8). In particular, -MHC is increased by tri-iodothyronine (T3), 16 
an active form of thyroid hormone, and -MHC is decreased (8). Moreover, the alterations 17 
in thyroid hormone signaling are associated with cardiac pathophysiology, such as 18 
hypertrophy and heart failure (8, 11). 19 
  In the present study, Dicer siRNA and 21 randomly selected miRNAs 20 
were individually transduced into neonatal rat ventricular myocytes (NRVMs) using a 21 
lentiviral vector, and MHC gene expression was evaluated. We showed that (1) 22 
 5 
down-regulation of Dicer, an essential enzyme for miRNA biosynthesis, globally reduced 1 
endogenous miRNAs, which resulted in the down-regulation of the -MHC gene, and (2) 2 
miR-27a was a novel factor that could regulate -MHC gene expression via thyroid 3 
hormone receptor 1 (TR1) in NRVMs.   4 
 5 
Materials and Methods 6 
Cell Culture 7 
  NRVMs were isolated from 1-day-old Sprague-Dawley rats as described 8 
previously (14). These cells were cultured in Dulbecco’s modified Eagle’s medium 9 
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% 10 




 6-well plates 11 
(BECTON DICKINSON) at 37°C in a 5% CO2 incubator. DNA transduction was carried 12 




  MicroRNA (miRNA)-expressing vectors, including miR-1, -15b, -16, -21, 17 
-22, -23a, -24, -27a, -29a, -30c, -125b, -126, -130a, -133b, -143, -146, -150a, -195, -199a, 18 
-208a, and -424, were constructed using a BLOCK-iT
™
 Pol II miR RNAi Expression 19 
Vector kit (Invitrogen) following the manufacturer’s instructions. A control miRNA 20 
expressing vector (Cont.miR) was obtained from the kit. For the construction of 21 
anti-miR-27a, double-stranded oligonucleotides containing three or six sequences that were 22 
 6 
completely complementary to miR-27a were inserted into a pMIR-REPORT
™
 vector 1 
(Ambion) at the Pme I site (miR-27a decoy) in accordance with previous studies (3, 9, 23). 2 
SiRNA vectors were constructed from pSINsi-mU6 DNA
™ 
(Takara Bio.). Double-stranded 3 
oligonucleotides were inserted into pSINsi-mU6 DNA
™ 
at the BamHI/ClaI sites. 4 
Oligonucleotides targeting specific genes and the control (Control siRNA) were as follows: 5 
Dicer siRNA 5’ -GGAATGGACTCTGAGCTTA- 3’; TR1 siRNA1 5’ -GGAATGTC- 6 
GCTTTAAGAAA- 3’; TR1 siRNA2 5’ -GGAAGCTGAAGAGAA- 3’; RXR siRNA1 7 
5’ -CAAGAGGACAGTACGCAAA- 3’; RXR siRNA2 5’ -CCAAGACTGAGACATAC- 8 
GT- 3’; Control siRNA 5’ -AATAATAATGGGGGGATCC- 3’. All of these constructs 9 
were inserted into a pLenti6/V5-D-TOPO
™
 vector (Invitrogen). The rat TR1 gene was 10 
amplified and cloned into a pLenti6/V5-D-TOPO vector using the following primers: 11 
forward 5’ -ATGACAGAAAATGGCCTTCCAGCCT- 3’, reverse 5’ -TCAGTCCTCA- 12 
AAGACTTCCAAGAA- 3’. The following primers were used to amplify and clone a part 13 
of the 3’UTR of the rat TR1 and THRAP1 and the human TR1 and THRAP2 into a 14 
pMIR-REPORT
™
 luciferase vector at the SpeI/HindIII sites in accordance with the 15 
manufacturer’s instructions: rat TR1 forward 5’ -GGACTAGTCAGACCATGCATAG- 16 
GAAACACCAT-3’, reverse 5’ -CCCAAGCTTCACCCACATGCATTCCGTTTCCGAA- 17 
3’; THRAP2 forward 5’ -CCGGGAAGCGCTTGCCCTCTGCCT-3’, reverse 5’ -AGCCC- 18 
CAGTGCTAGAT CCTGTACT- 3’; human TR1  forward 5’ -ACAAGCCCTGGCCC- 19 
CTCCTCGACA- 3’, reverse 5’ - GCACAGTAAAATTCTGTGATAAG- 3’; THRAP1 20 
forward 5’ -GACTTACTAATGTACTGTCACAGA- 3’, reverse 5’ -ATACAGTAATCT- 21 
GTGCCATACTGA- 3’. The rat -MHC luciferase promoter construct consisted of the 22 
 7 
firefly luciferase cDNA driven by a 333-bp rat -MHC promoter sequence (13).  1 
 2 
Lentivirus Production and DNA Transduction 3 
  Lentiviral stocks were produced in 293FT cells following the 4 
manufacturer’s protocol (Invitrogen). In brief, virus-containing medium was collected 48 h 5 
post-transfection and filtered through
 
a 0.45-µm filter. One round of lentiviral infection was 6 
performed by
 
replacing the medium with virus-containing
 
medium with 8 µg/ml of
 
7 
polybrene, followed by centrifugation at 2,500 rpm for 30 min at 32°C. 8 
 9 
RNA Extraction and Quantitative Real-time PCR (qRT-PCR) 10 
  Total RNA
 
was isolated and purified from NRVMs using TRIzol
™
 11 
reagent (Invitrogen), and cDNA was synthesized from 5 g of total RNA using 12 
SuperScriptII
™
 reverse transcriptase (Invitrogen) in accordance with the manufacturer’s 13 
instructions. For qRT-PCR, specific genes were amplified by 40 cycles using SYBR
™ 
14 
Green PCR Master Mix (Applied Biosystems). Expression was normalized to the 15 
housekeeping gene GAPDH. The primers used were as follows: GAPDH forward 5’ 16 
-TTGCCATCAACGACCCCTTC- 3’, reverse 5’ -TTGTCATGGATGACCTTGGC- 3’; 17 
Dicer forward 5’ -ATGCGATTTTGGACTACCTCATAAC- 3’, reverse 5’ -TCAGCTG- 18 
TTAGGAACCTGAGGCTGG- 3’; -MHC forward 5’ -GACACCAGCGCCCACCTG- 3’, 19 
reverse 5’ -ATAGCAACAGCGAGGCTCTTTCTG- 3’; -MHC forward 5’ -GGAGCT- 20 
CACCTACCAGACAGA- 3’, reverse 5’ -CTCAGGGCTTCACAGGCATCC- 3’; total 21 
MHC forward 5' -GAGGCGGTGCAGGAGTGTAG-3', reverse 5' -ACCTGGGACT- 22 
 8 
CGGCAATGTC- 3'; TR1 forward 5’ -AGCCAGCCACAGCACAGTGA- 3’, reverse 5’ 1 
-CGCCAGAAGACTGAAGCTTGC- 3’; DDR2 forward 5' -AGTCAGTGGTCAGAGT- 2 
CCACAGC- 3', reverse 5' -CAGGGCACCAGGCTCCATC- 3'. We used TaqMan 3 
MicroRNA Assays
TM
 (Applied Biosystems) to determine the expression levels of miRNAs 4 
in accordance with the manufacturer's instructions. 5 
  6 
Northern Blotting Analysis 7 
  Northern blotting analysis was performed as described previously (25). In 8 
brief, small RNA fractions were isolated from total RNA using a mirVana miRNA 9 
Isolation
TM
 kit (Ambion). The small RNA fractions, 5 μg, were separated by 10 
electrophoresis using a 15% polyacrylamide (19:1) denaturing gel and transferred to nylon 11 
hybridization membrane (Hybond-NX; Amersham) using a semidry electroblotter (Bio-Rad, 12 
Hercules, CA, USA) at 20 V for 30 min at 4°C. Cross-linking of RNA was performed using 13 
0.16 M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC; Sigma) in 0.13 M 14 
1-methylimidazole (Sigma) at pH 8.0 for 2 h at 60°C. Templates to make probes for 15 
miR-16, miR-133b, and U6 were prepared using a mirVana miRNA Probe Construction 16 
Kit
TM
 (Ambion) with the following oligonucleotides: miR-16 5' -TAGCAGCAC- 17 
GTAAATATTGGCGCCTGTCTC- 3'; miR-133b 5' -TTGGTCCCCTTCAACCAGAC- 18 
CTGTCTC- 3'; U6 5' -CGATACAGAGAAGATTAGCATGGCCCCTGCCCTGTCTC- 3'.  19 
 20 
Luciferase Assay 21 
 9 
  For luciferase reporter assays, constructs were transiently transfected 1 
using Fugene 6
™ 
(Roche) into 293FT cells or using Lipofectamine 2000
™
 (Invitrogen) into 2 
NRVMs at the following concentrations: 0.1 g of firefly luciferase reporter gene, 0.01 g 3 
of pRL-TK
™
 Renilla reniformis luciferase control plasmid (Promega), and 0.1 g of 4 
BLOCK-iT Pol II miR RNAi Expression Vector
TM
 encoding the appropriate miRNA or the 5 
control. At 24 h after transfection, both luciferase activities were measured using a dual 6 
luciferase reporter assay system (Toyo Ink Co.). Firefly luciferase activity was normalized 7 
for transfection efficiency by measuring that of renilla reniformis control activity in 8 
accordance with the manufacturer’s instructions. 9 
  10 
Western Immunoblotting Analysis 11 
  Immunoblotting analysis was performed using standard procedures as 12 
described previously (38). Cultured cells were homogenized in lysis buffer consisting of 13 
100 mM Tris-HCl, pH 7.4, 75 mM NaCl and 1% Triton
™
 X -100 (Nacalai Tesque). The 14 
buffer was supplemented with Complete Mini
™ 
protease inhibitor (Roche), 0.5 mM NaF, 15 
and 10 M Na3VO4 just prior to use. The protein concentration was determined using a 16 
BCA protein assay kit (BIORAD). A total of 2 or 10 g of protein was fractionated using 17 
NUPAGE
™
 4-12% Bis-Tris (Invitrogen) gels and transferred to PROTRAN
™
 nitrocellulose 18 
transfer membrane (Whatman). The membrane was blocked using 1×PBS containing 5% 19 
non-fat milk for 1 h and incubated with the primary antibody overnight at 4°C. Following a 20 
wash step in 0.05% T-PBS (1×PBS and 0.05% Tween-20), the membrane was incubated 21 
with the secondary antibody for 1 h at 4°C. After washing the membrane in 0.05% T-PBS, 22 
 10 
the immunocomplexes were detected using ECL
™
 Western Blotting Detection Reagent 1 
(Amersham Biosciences). The primary antibodies used were: anti-GAPDH (Cell Signaling 2 
Technology), 1:1,000; anti-Dicer (sc-25117, Santa Cruz Biotechnology, Inc.), 1:500; 3 
anti--MHC (ab50967, Abcam), 1:20,000; anti-skeletal slow myosin (M8421, Sigma) for 4 
detecting -MHC, 1:20,000; anti-TR1 (sc-738, Santa Cruz Biotechnology, Inc.), 1:500; 5 
and anti-RXR (sc-553, Santa Cruz Biotechnology, Inc.), 1:500. As secondary antibodies, 6 
anti-rabbit, anti-mouse, and anti-goat IgG (GE Healthcare) as used at a dilution of 1:2,000. 7 
Immunoblots were detected using an LAS-1000 system (FUJI FILM). 8 
  9 
Statistics 10 
  Data are presented as means ± S.E. Statistical comparisons were 11 
performed using unpaired two-tailed Student’s t-tests where appropriate, with a probability 12 
value of <0.05 was taken to indicate significance. 13 
 14 
Results 15 
Dicer siRNA can down-regulate endogenous miRNAs and the -MHC gene in NRVMs 16 
  To investigate the effects of miRNAs on cardiac MHC gene expression, 17 
we first tried to suppress the function of endogenous miRNAs in NRVMs. Because Dicer is 18 
an essential enzyme for miRNA biosynthesis, it was hypothesized that the down-regulation 19 
of Dicer could result in a global reduction of miRNAs, which equates to a loss-of-function 20 
of miRNAs. Dicer siRNA was transduced into NRVMs using a lentiviral vector, which 21 
resulted in the down-regulation of both Dicer mRNA and protein in serum-containing 22 
 11 
conditions (Figs. 1A and B). Moreover, Dicer siRNA could down-regulate ubiquitously 1 
expressed miR-16 and muscle-specific miR-133b at the same time (Fig. 1C), suggesting the 2 
global reduction of endogenous miRNAs in NRVMs. The MHC gene has two isoforms, - 3 
and -MHC, and the gene expression of both isoforms was assessed in NRVMs into which 4 
Dicer siRNA was transduced. As a result, Dicer siRNA decreased both mRNA and protein 5 
levels of -MHC but not those of -MHC, while total MHC mRNA levels were not altered 6 
(Fig. 1D and E). These results indicated that a loss-of-function of miRNAs could suppress 7 
-MHC gene expression specifically in NRVMs in serum-containing conditions, and there 8 
were specific miRNAs that can up-regulate -MHC gene expression.       9 
 10 
miR-27a can up-regulate the -MHC gene in NRVMs 11 
  To identify miRNAs that can up-regulate -MHC gene expression, 21 12 
randomly selected miRNAs were individually transduced into NRVMs using a lentiviral 13 
vector, and mRNA levels of -MHC were examined in serum-containing conditions. As a 14 
result, miR-27a was found to increase -MHC mRNA levels most strongly among the 15 
miRNAs assessed, while several miRNAs, such as miR-22, -23a, 29a, and -30c, could 16 
increase -MHC levels to a lesser extent (Fig. 2A). The lentiviral vector could express 17 
miR-27a abundantly in NRVMs (Fig. 2B). Next, to study whether endogenous miR-27a 18 
was expressed in cardiac myocytes, miR-27a levels were examined both in NRVMs and 19 
cardiac fibroblasts. The appropriate separation between both types of cells was confirmed 20 
by detecting the mRNA of -MHC, a myocyte-specific marker, or collagen receptor 21 
 12 
Discoidin Domain Receptor 2 (DDR2), a cardiac fibroblast-specific marker (2) (Fig. 2C). 1 
As a result, miR-27a was found to be expressed in cardiac myocytes but not cardiac 2 
fibroblasts (Fig. 2D). Further examination of miR-27a confirmed that over-expression of 3 
miR-27a in NRVMs could increase -MHC gene expression both at mRNA and protein 4 
levels in serum-containing conditions but did not affect those of -MHC (Figs. 2E and F). 5 
These findings suggested that the up-regulation of miR-27a could up-regulate -MHC gene 6 
expression in cardiac myocytes. 7 
 8 
Loss-of-Function of miR-27a Decreases -MHC Protein Levels in NRVMs 9 
  To examine the direct effect of miR-27a on -MHC gene regulation, 10 
-MHC protein expression was also assessed in NRVMs in which miR-27a function was 11 
suppressed. NRVMs infected with a lentiviral vector were used in which a 3’UTR with 12 
three or six tandem miR-27a decoy sequences complementary to miR-27a was linked to the 13 
luciferase reporter gene in accordance with previous studies (Fig. 3A) (3, 9, 23). The 14 
complementary sequences acted as a decoy, sequestering endogenous miR-27a. When 15 
miR-27a was transfected into 293FT cells along with miR-27a decoy*6, the luciferase 16 
activity of the decoy was significantly reduced (Fig. 3B). On the other hand, miR-1, -21, 17 
-133b, and -208a did not affect luciferase activity (Fig. 3B). Next, miR-27a decoys were 18 
transfected into NRVMs, which resulted in the reduction of luciferase activity. These 19 
results indicated that miR-27a decoys could specifically bind to endogenous miR-27a (Fig. 20 
3C). When miR-27a decoys were transduced into NRVMs using a lentiviral vector, -MHC 21 
protein levels decreased but those of -MHC did not change in serum-containing 22 
 13 
conditions (Fig. 3D and E). These results suggested that miR-27a is directly involved in 1 
-MHC gene regulation in NRVMs.  2 
 3 
Target prediction of miR-27a 4 
  To find targets of miR-27a that can regulate -MHC gene expression, a 5 
search was made for putative target genes of miR-27a using Target Scan
TM
, a 6 
bioinformatics tool for miRNA target prediction. Because miRNAs suppress gene 7 
expression, it was supposed that over-expression of miR-27a could down-regulate target 8 
genes that can negatively regulate -MHC expression, which might result in up-regulation 9 
of the -MHC gene. Transcription factors that can negatively regulate -MHC gene 10 
transcription or related co-regulators were expected to be involved in this up-regulation of 11 
the -MHC gene. There are several transcription factors that bind to the rat -MHC 12 
promoter, and one of negative regulators of -MHC, thyroid hormone receptor 1 (TR1) 13 
(12), was predicted as one of targets of miR-27a according to Target Scan
TM 
(Fig. 4A). 14 
TR1 binds to a negative thyroid hormone responsive element in the -MHC promoter and 15 
negatively regulates -MHC transcription (18, 22). To test whether the putative target 16 
sequence in the 3’UTR of TR1 could mediate translational repression, the 3’UTR of TR1 17 
was inserted into a luciferase reporter construct, which was transfected into 293FT cells, 18 
and CMV-driven miR-27a consequently decreased the luciferase activity of the construct 19 
(Fig. 4A). The human TR1 mRNA was predicted to have other binding sites for miR-27a, 20 
and the luciferase activity of a human TR1 3'UTR reporter was decreased significantly by 21 
 14 
miR-27a (Fig. 4B). These findings suggested that the binding sites of miR-27a in the 1 
3’UTR of TR1 could mediate translational repression by miR-27a. Thyroid hormone 2 
receptors form a homo-dimer, or hetero-dimer with retinoid X receptorsand associate with 3 
nuclearproteins such as thyroid hormone receptor associated proteins Retinoid X 4 
receptor RXR and thyroid hormone receptor associated protein 1 and 2 were predicted 5 
as targets of miR-27a according to Target Scan
TM
. A recent study revealed that miR-27a 6 
can target RXR in rat hepatic cell lines (17), while thyroid hormone receptor associated 7 
protein 1 and 2 could not be demonstrated as targets of miR-27a (Figs. 4C and D).     8 
 9 
miR-27a targets thyroid hormone receptor beta 1(TR1) 10 
 To test whether miR-27a could actually target TR1, TR1 gene expression was 11 
examined in NRVMs transduced with miR-27a or miR-27a decoys. As a result, miR-27a 12 
decreased TR1 protein levels without affecting TR1 mRNA levels in NRVMs (Figs. 5A 13 
and B), and miR-27a decoys increased TR1 protein levels (Fig. 5C). These findings 14 
indicated that TR1 is a target of miR-27a. Next, it was examined whether 15 
RXRsiRNAcould increase -MHC gene expression in NRVMs. RXR siRNAs did not 16 
increase -MHC protein levels in serum-containing conditions (Fig. 5D), whereas TR1 17 
siRNAs increased -MHC protein levels (Fig. 5E). Because miR-27a could up-regulate the 18 
-MHC gene in serum-containing conditions, these results indicated that the up-regulation 19 
of -MHC by miR-27a resulted mainly from the down-regulation of TR1 rather than 20 
RXR.  21 
 15 
Over-expression of miR-27a attenuates thyroid hormone effect   1 
  . To examine whether miR-27a regulates -MHC gene expression via 2 
TR1, miR-27a- or miR-27a decoy-transduced NRVMs were treated with tri-iodothyronine 3 
(T3), a ligand of thyroid hormone receptors, and -MHC protein expression was assessed. 4 
Treatment of NRVMs with 10  nM T3 could significantly up-regulate -MHC and 5 
down-regulate -MHC protein levels (Fig. 6A), which was the same result as the previous 6 
studies (10, 18, 21). Over-expression of miR-27a attenuated the effect of T3, which can 7 
decrease -MHC protein levels but did not affect those of -MHC (Fig. 6A). The same 8 
result was obtained as that with TR1 siRNAs (Fig. 6B). RXR siRNAs down-regulated 9 
-MHC protein in the absence of T3, whereas in the presence of T3 -MHC protein levels 10 
did not change (Fig. 6C).  11 
 12 
miR-27a regulates -MHC protein expression via TR1 13 
  To confirm the specific effect of miR-27a on thyroid hormone signaling in 14 
-MHC gene expression, -MHC protein levels were examined in NRVMs transduced with 15 
miR-27a decoys. As a result, miR-27a decoys facilitated the down-regulation of -MHC 16 
protein by 10 nM T3 treatment (Fig. 7A), which was the opposite to that of miR-27a 17 
over-expression. Next, to elucidate the effects of up-regulation of TR1 on -MHC gene 18 
expression, the rat TR1 gene was transduced into NRVMs using a lentiviral vector (Fig. 19 
7B), and -MHC protein expression was assessed. As a result, over-expression of TR1 20 
promoted the down-regulation of -MHC protein in the presence of 10 nM T3, while in the 21 
 16 
absence of T3, -MHC gene expression did not change significantly (Figs. 7C and D), 1 
which was the same result as that with miR-27a decoys (Fig. 7A). On the other hand, TR1 2 
over-expression could decrease the luciferase activity of the -MHC promoter construct, 3 
which contained a 333-bp rat -MHC promoter sequence even in the absence of T3 (Fig. 4 
7E). In serum-containing conditions, TR1 also down-regulated -MHC protein levels but 5 
did not change -MHC protein levels (data not shown), which was the same result as with 6 
miR-27a decoys (Figs. 3D and E). These findings indicated that miR-27a regulates -MHC 7 
gene expression via TR1. 8 
 9 
Discussion 10 
  Extensive research into the functions of miRNAs in the cardiovascular 11 
system has been performed. However, it is challenging to distinguish the direct effects of a 12 
specific miRNA from a range of indirect consequences because a miRNA may 13 
down-regulate several hundred target genes at the same time. In in vivo studies, many 14 
environmental factors, such as cytokines, neurohormones and hemodynamics, or 15 
interactions with interstitial components are considered to strongly affect the gene 16 
regulation of cardiac myocytes, which makes it more difficult to evaluate the direct effects 17 
of individual miRNAs. Therefore, in the present study, it was attempted to examine the 18 
direct effects of miRNAs on cardiac gene regulation using primary cultures of NRVMs, in 19 
which the environmental factors or the interactions with interstitial components were 20 
limited. 21 
  We first tried to suppress global miRNA function in NRVMs by siRNA 22 
 17 
against Dicer, an essential enzyme for miRNA biosynthesis, and elucidate the effects on 1 
cardiac MHC gene expression. It had been controversial whether Dicer siRNA could 2 
down-regulate Dicer itself because gene suppression by siRNAs requires processing by 3 
Dicer. The present data revealed that Dicer siRNA could down-regulate both Dicer and 4 
mature miRNAs, including ubiquitous miR-16 and muscle-specific miR-133b, at the same 5 
time in NRVMs, suggesting the global reduction of miRNAs by Dicer siRNA.  6 
  The present study showed that Dicer siRNA could down-regulate the 7 
-MHC gene even though Dicer siRNA did not completely delete mature miRNAs. A 8 
previous study has demonstrated that cardiac-specific Dicer-deficient mice, in which 9 
mature miRNAs are globally reduced but can be detected, die shortly after birth presenting 10 
cardiac dysfunction (4). These findings suggested that miRNAs were relatively stable in 11 
this expression system, and the dysregulation of miRNA machinery could significantly 12 
affect cellular function and gene regulation in the heart. However, it remained unclear 13 
whether the observed events, resulting from Dicer knock-down or knock-out, were derived 14 
from the global reduction of miRNAs or the dysregulation of Dicer itself or both.  15 
  Targeted Dicer deletion through use of a tamoxifen-inducible Cre 16 
recombinase in the hearts of 8-week-old mice can result in the up-regulation of -MHC 17 
mRNA levels (7), whereas -MHC protein levels in cardiac specific Dicer-deficient mice, 18 
which die shortly after birth, are unchanged (4). The present data demonstrated that Dicer 19 
siRNA could down-regulate the -MHC gene. These differences in results might be derived 20 
from the age at which -MHC gene expression is different between perinatal and adult 21 
mice or the neurohormonal and hemodynamic effect in vivo, which are considered to 22 
 18 
strongly influence the regulation of genes such as -MHC (24, 26) but have minimally 1 
effect in vitro.   2 
 We demonstrated that thyroid hormone receptor 1 (TR1) is a novel 3 
target gene of miR-27a. Among the predicted genes as targets of miR-27a by Target 4 
Scan
TM
, TR1 was clearly one that could be involved in the negative regulation of -MHC 5 
gene expression. TR1 has been already reported as a negative regulator of -MHC 6 
transcription (12, 18). In the present data, over-expression of miR-27a decreased TR1 7 
protein levels without affecting mRNA levels. Moreover, miR-27a suppressed the 8 
luciferase activity of the TR1 3’UTR luciferase reporter construct, while miR-27a decoys 9 
increased TR1 protein expression. These findings suggested that miR-27a could regulate 10 
TR1 post-transcriptionally. 11 
 Target Scan
TM
 also predicted thyroid hormone receptor associated protein 12 
1 and 2 and retinoid X receptor RXR as the targets of miR-27a. Thyroid hormone 13 
receptors form a hetero-dimer with retinoid X receptors and associate with nuclearproteins, 14 
such as thyroid hormone receptor associated proteins  However, the 3’UTR luciferase 15 
reporter assay did not show that miR-27a could target thyroid hormone receptor associated 16 
protein 1 or 2. RXR has been reported as the target of miR-27a (17), but in the presence of 17 
serum, RXR siRNAs did not alter -MHC protein levels, while TR1 siRNA could 18 
increase -MHC protein levels in a same manner as miR-27a. These results suggested that 19 
miR-27a regulates -MHC gene expression predominantly via TR1 in NRVMs. 20 
 Here, we demonstrated that miR-27a could modulate thyroid hormone 21 
 19 
signaling in -MHC gene expression. The present study demonstrated that the 1 
down-regulation of TR1 by miR-27a over-expression or TR1 siRNA attenuated the 2 
effect of 10 nM T3, which could down-regulate -MHC protein levels. On the other hand, 3 
miR-27a decoy enhanced the effect of T3 treatment on -MHC protein expression in a 4 
same manner as TR1 over-expression. MHC gene expression is strongly regulated by 5 
thyroid hormone and receptors. Thyroid hormone receptors have four main isoforms, 1, 6 
2, 1 and 2 (19). Isoforms 1, 2, and 1 are expressed differentially but rather 7 
ubiquitously, whileisoform 2 exhibits restricted tissue distribution, being found mainly in 8 
the pituitary gland (15, 19, 28). TR1 regulates -MHC transcription in NRVMs but not 9 
-MHC (18). The present data also revealed that -MHC protein levels were not affected 10 
by TR1 in NRVMs. Moreover, TR1 and 2 cannot be directly involved in the regulation 11 
of -MHC transcription in NRVMs (18). These findings suggested that miR-27a can 12 
modulate thyroid hormone signaling specifically in -MHC gene regulation via TR1 in 13 
NRVMs. Ｉn the absence of T3, over-expression of TR1 or miR-27a decoy did not 14 
significantly decrease either -MHC mRNA or protein levels. It has been reported that 15 
-MHC transcription can be suppressed by TR1 over-expression even in the absence of 16 
T3 in NRVMs (18), and unliganded TR can suppress basal transcription (32). In these 17 
previous studies, -MHC transcription was evaluated using a CAT promoter assay (18) or 18 
by a cell-free transcription assay (32). The present study also showed that even in the 19 
absence of T3, TR1 over-expression could decrease the luciferase activity of the -MHC 20 
promoter construct, which contained a 333-bp rat -MHC promoter sequence, but not 21 
 20 
-MHC mRNA and protein levels. Therefore, mRNA and protein stability or promoter 1 
regulation might be different between reporter genes and the -MHC gene. 2 
 In serum-free conditions, or T3-free conditions in this study, the effect of 3 
TR1 on -MHC gene regulation was very weak, whereas TR1 significantly changed 4 
-MHC expression levels, which suggested that factors in the serum could modulate 5 
-MHC gene regulation by TR1. Serum-containing medium used in this study was found 6 
to contain T3 at a concentration of 1.12 ± 0.12 nM (data not shown). According to a 7 
previous report, 1 and 10 nM T3 can both decrease -MHC mRNA levels to a minimum in 8 
cardiomyocytes (18). These findings suggested that T3 in the serum might modulate 9 
-MHC gene regulation by miR-27a, although there was a possibility that other factors 10 
might also be involved in this gene regulation. 11 
 In summary, miR-27a can regulate -MHC gene expression by targeting 12 
TR1 in NRVMs.   13 
 14 
Acknowledgements 15 
  This work was supported in part by a Grant-in-Aid for Scientific Research 16 
from the Ministry of Education, Culture, Sports, Science and Technology of Japan to K. 17 
Ono, K. Hasegawa, and T. Kita. 18 
 19 





1. Callis, T. E., K. Pandya, H. Y. Seok, R. H. Tang, M. Tatsuguchi, Z. P. Huang, J. 3 
F. Chen, Z. Deng, B. Gunn, J. Shumate, M. S. Willis, C. H. Selzman, and D. Z. 4 
Wang. 2009. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction 5 
in mice. J Clin Invest 119:2772-86. 6 
2. Camelliti, P., T. K. Borg, and P. Kohl. 2005. Structural and functional 7 
characterisation of cardiac fibroblasts. Cardiovasc Res 65:40-51. 8 
3. Care, A., D. Catalucci, F. Felicetti, D. Bonci, A. Addario, P. Gallo, M. L. Bang, 9 
P. Segnalini, Y. Gu, N. D. Dalton, L. Elia, M. V. Latronico, M. Hoydal, C. 10 
Autore, M. A. Russo, G. W. Dorn, 2nd, O. Ellingsen, P. Ruiz-Lozano, K. L. 11 
Peterson, C. M. Croce, C. Peschle, and G. Condorelli. 2007. MicroRNA-133 12 
controls cardiac hypertrophy. Nat Med 13:613-8. 13 
4. Chen, J. F., E. P. Murchison, R. Tang, T. E. Callis, M. Tatsuguchi, Z. Deng, M. 14 
Rojas, S. M. Hammond, M. D. Schneider, C. H. Selzman, G. Meissner, C. 15 
Patterson, G. J. Hannon, and D. Z. Wang. 2008. Targeted deletion of Dicer in the 16 
heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A 17 
105:2111-6. 18 
5. Cheng, Y., R. Ji, J. Yue, J. Yang, X. Liu, H. Chen, D. B. Dean, and C. Zhang. 19 
2007. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a 20 
role in cardiac hypertrophy? Am J Pathol 170:1831-40. 21 
6. Cullen, B. R. 2004. Transcription and processing of human microRNA precursors. 22 
 22 
Mol Cell 16:861-5. 1 
7. da Costa Martins, P. A., M. Bourajjaj, M. Gladka, M. Kortland, R. J. van Oort, 2 
Y. M. Pinto, J. D. Molkentin, and L. J. De Windt. 2008. Conditional dicer gene 3 
deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. 4 
Circulation 118:1567-76. 5 
8. Dillmann, W. 2009. Cardiac hypertrophy and thyroid hormone signaling. Heart Fail 6 
Rev. 7 
9. Ebert, M. S., J. R. Neilson, and P. A. Sharp. 2007. MicroRNA sponges: 8 
competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4:721-6. 9 
10. Edwards, J. G., J. J. Bahl, I. L. Flink, S. Y. Cheng, and E. Morkin. 1994. 10 
Thyroid hormone influences beta myosin heavy chain (beta MHC) expression. 11 
Biochem Biophys Res Commun 199:1482-8. 12 
11. Galli, E., A. Pingitore, and G. Iervasi. The role of thyroid hormone in the 13 
pathophysiology of heart failure: clinical evidence. Heart Fail Rev 15:155-69. 14 
12. Gupta, M. P. 2007. Factors controlling cardiac myosin-isoform shift during 15 
hypertrophy and heart failure. J Mol Cell Cardiol 43:388-403. 16 
13.  Hasegawa, K., S. J. Lee, S. M. Jobe, B. E. Markham, and R. N. Kitsis. 1997. 17 
cis-Acting sequences that mediate induction of beta-myosin heavy chain gene 18 
expression during left ventricular hypertrophy due to aortic constriction. Circulation 19 
96:3943-53. 20 
14. Hasegawa, K., M. B. Meyers, and R. N. Kitsis. 1997. Transcriptional Coactivator 21 
p300 Stimulates Cell Type-specific Gene Expression in Cardiac Myocytes. J. Biol. 22 
 23 
Chem. 272:20049-20054. 1 
15. Hodin, R. A., M. A. Lazar, and W. W. Chin. 1990. Differential and 2 
tissue-specific regulation of the multiple rat c-erbA messenger RNA species by 3 
thyroid hormone. J Clin Invest 85:101-5. 4 
16. Ikeda, M., M. Rhee, and W. W. Chin. 1994. Thyroid hormone receptor monomer, 5 
homodimer, and heterodimer (with retinoid-X receptor) contact different nucleotide 6 
sequences in thyroid hormone response elements. Endocrinology 135:1628-38. 7 
17. Ji, J., J. Zhang, G. Huang, J. Qian, X. Wang, and S. Mei. 2009. Over-expressed 8 
microRNA-27a and 27b influence fat accumulation and cell proliferation during rat 9 
hepatic stellate cell activation. FEBS Lett 583:759-66. 10 
18. Kinugawa, K., K. Yonekura, R. C. Ribeiro, Y. Eto, T. Aoyagi, J. D. Baxter, S. 11 
A. Camacho, M. R. Bristow, C. S. Long, and P. C. Simpson. 2001. Regulation of 12 
thyroid hormone receptor isoforms in physiological and pathological cardiac 13 
hypertrophy. Circ Res 89:591-8. 14 
19. Lazar, M. A. 1993. Thyroid hormone receptors: multiple forms, multiple 15 
possibilities. Endocr Rev 14:184-93. 16 
20. Liu, N., S. Bezprozvannaya, A. H. Williams, X. Qi, J. A. Richardson, R. 17 
Bassel-Duby, and E. N. Olson. 2008. microRNA-133a regulates cardiomyocyte 18 
proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 19 
22:3242-54. 20 
21. Lompre, A. M., B. Nadal-Ginard, and V. Mahdavi. 1984. Expression of the 21 
cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally 22 
 24 
and hormonally regulated. J Biol Chem 259:6437-46. 1 
22. Morkin, E. 2000. Control of cardiac myosin heavy chain gene expression. Microsc 2 
Res Tech 50:522-31. 3 
23.   Nishi, H., K. Ono, Y. Iwanaga, T. Horie, K. Nagao, G. Takemura, M. Kinoshita, 4 
Y. Kuwabara, R. T. Mori, K. Hasegawa, T. Kita, and T. Kimura. 5 
MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via 6 
Arl2 in neonatal rat cardiac myocytes. J Biol Chem 285:4920-30. 7 
24. Ojamaa, K., J. D. Klemperer, S. S. MacGilvray, I. Klein, and A. Samarel. 1996. 8 
Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain 9 
promoter in the heart. Endocrinology 137:802-8. 10 
25. Pall, G. S., C. Codony-Servat, J. Byrne, L. Ritchie, and A. Hamilton. 2007. 11 
Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the 12 
detection of siRNA, miRNA and piRNA by northern blot. Nucleic Acids Res 13 
35:e60. 14 
26. Qi, M., K. Ojamaa, E. G. Eleftheriades, I. Klein, and A. M. Samarel. 1994. 15 
Regulation of rat ventricular myosin heavy chain expression by serum and 16 
contractile activity. Am J Physiol 267:C520-8. 17 
27. Sayed, D., C. Hong, I. Y. Chen, J. Lypowy, and M. Abdellatif. 2007. 18 
MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ 19 
Res 100:416-24. 20 
28. Strait, K. A., H. L. Schwartz, A. Perez-Castillo, and J. H. Oppenheimer. 1990. 21 
Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding 22 
 25 
capacity and function in developing and adult rats. J Biol Chem 265:10514-21. 1 
29. Sucharov, C., M. R. Bristow, and J. D. Port. 2008. miRNA expression in the 2 
failing human heart: functional correlates. J Mol Cell Cardiol 45:185-92. 3 
30. Tatsuguchi, M., H. Y. Seok, T. E. Callis, J. M. Thomson, J. F. Chen, M. 4 
Newman, M. Rojas, S. M. Hammond, and D. Z. Wang. 2007. Expression of 5 
microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell 6 
Cardiol 42:1137-41. 7 
31. Thum, T., P. Galuppo, C. Wolf, J. Fiedler, S. Kneitz, L. W. van Laake, P. A. 8 
Doevendans, C. L. Mummery, J. Borlak, A. Haverich, C. Gross, S. Engelhardt, 9 
G. Ertl, and J. Bauersachs. 2007. MicroRNAs in the human heart: a clue to fetal 10 
gene reprogramming in heart failure. Circulation 116:258-67. 11 
32. Tong, G. X., M. Jeyakumar, M. R. Tanen, and M. K. Bagchi. 1996. 12 
Transcriptional silencing by unliganded thyroid hormone receptor beta requires a 13 
soluble corepressor that interacts with the ligand-binding domain of the receptor. 14 
Mol Cell Biol 16:1909-20. 15 
33. van Rooij, E., W. S. Marshall, and E. N. Olson. 2008. Toward microRNA-based 16 
therapeutics for heart disease: the sense in antisense. Circ Res 103:919-28. 17 
34. van Rooij, E., L. B. Sutherland, N. Liu, A. H. Williams, J. McAnally, R. D. 18 
Gerard, J. A. Richardson, and E. N. Olson. 2006. A signature pattern of 19 
stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. 20 
Proc Natl Acad Sci U S A 103:18255-60. 21 
35. van Rooij, E., L. B. Sutherland, X. Qi, J. A. Richardson, J. Hill, and E. N. 22 
 26 
Olson. 2007. Control of stress-dependent cardiac growth and gene expression by a 1 
microRNA. Science 316:575-9. 2 
36. van Rooij, E., L. B. Sutherland, J. E. Thatcher, J. M. DiMaio, R. H. Naseem, W. 3 
S. Marshall, J. A. Hill, and E. N. Olson. 2008. Dysregulation of microRNAs after 4 
myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad 5 
Sci U S A 105:13027-32. 6 
37. Weiss, A., and L. A. Leinwand. 1996. The mammalian myosin heavy chain gene 7 
family. Annu Rev Cell Dev Biol 12:417-39. 8 
38. Yanazume, T., K. Hasegawa, T. Morimoto, T. Kawamura, H. Wada, A. 9 
Matsumori, Y. Kawase, M. Hirai, and T. Kita. 2003. Cardiac p300 Is Involved in 10 
Myocyte Growth with Decompensated Heart Failure. Mol. Cell. Biol. 11 
23:3593-3606. 12 
39. Zhao, Y., J. F. Ransom, A. Li, V. Vedantham, M. von Drehle, A. N. Muth, T. 13 
Tsuchihashi, M. T. McManus, R. J. Schwartz, and D. Srivastava. 2007. 14 
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking 15 








Figure Legends 1 
 2 
Figure. 1 Dicer siRNA down-regulates endogenous miRNAs and -MHC gene levels. 3 
Assays were performed 72 h (A through D) or 96 h (E) after transduction with Dicer siRNA 4 
or control siRNA (Cont.siRNA) into NRVMs using a lentiviral vector. A and B, mRNA 5 
(A) and protein (B) levels of Dicer. C, Endogenous miR-16 and miR-133b were detected by 6 
northern blotting analysis. D and E, mRNA and protein levels of -MHC, -MHC, and 7 
total MHC were detected by qRT-PCR (D) and immunoblotting (E). Representative data 8 
are presented as mean ± S.E. for three independent experiment (＊, P<0.05; ＊＊＊, P<0.001 9 
versus Cont. siRNA).  10 
 11 
Figure. 2 miR-27a up-regulates -MHC gene expression. Assays were performed 72 h 12 
after transduction with individual miRNAs or miR-control (Cont.miR) into NRVMs using a 13 
lentiviral vector. NRVMs were cultured in serum-containing medium. A, mRNA levels of 14 
-MHC in NRVMs transduced with individual miRNAs were detected by qRT-PCR. B, 15 
Expression levels of miR-27a or miR-195 in NRVMs transduced with miR-27a or 16 
Cont.miR using a lentiviral vector. C, mRNA levels of myocyte-specific -MHC (white 17 
bar) and cardiac fibroblast-specific DDR2 (black bar) both in NRVMs and cardiac 18 
fibroblasts. The bar graph indicates values expressed as relative -MHC (scale; left Y axis) 19 
and DDR2 (scale; right Y axis) mRNA levels compared with that of untreated NRVMs. D, 20 
Endogenous miR-27a levels in NRVMs and cardiac fibroblasts were detected by qRT-PCR. 21 
E, mRNA levels of - and -MHC were detected by qRT-PCR. Data are presented as mean 22 
 28 
± S.E. for three independent experiments (＊, P<0.05 versus Cont.miR). F, A total of 2 g of 1 
protein was used for immunoblotting of - and -MHC. Data are representative of three 2 
independent experiments. In A and C, the bar graph indicates values expressed as relative 3 
mRNA levels compared with Cont.miR. 4 
 5 
Figure. 3 miR-27a decoys decrease -MHC protein levels. A, Structure of “miR-27a 6 
decoy”. B, 293FT cells were transfected with a luciferase decoy construct (miR-27a decoys 7 
or control decoy) along with an expression plasmid for individual miRNAs or miR-control 8 
(Cont.miR). C, miR-27a decoys and control decoy (Cont.decoy) were transfected into 9 
NRVMs. The bar graph indicates values expressed as relative luciferase activity compared 10 
with that of the control. Data presented as mean ± S.E. of three independent experiments (＊, 11 
P<0.05; ＊＊,  P<0.01; ＊＊＊, P<0.001 versus control). D and E, NRVMs were transduced 12 
with miR-27a decoys using a lentiviral vector in serum-containing medium. Assays were 13 
performed 72 h after transduction. A total of 2 g of protein was used for immunoblotting 14 
of -MHC (D) and -MHC (E). Data are representative of three independent experiments.  15 
 16 
Figure. 4 Target prediction of miR-27a associated with negative TRE in the -MHC 17 
promoter. The predicted binding sites of miR-27a in the 3’UTR.oｆ predicted target gene. 18 
293FT cells were transfected with each of the 3’UTR luciferase construct and an expression 19 
plasmid for miR-27a or miR-control (Cont.miR). Rat TR1 (A), human TR1 (B), human 20 
thyroid hormone receptor associated protein 1 (THRAP1) (C), and rat THRAP2 (D). Data 21 
 29 
are presented as mean ± S.E. of three independent experiments (＊, P<0.05; ＊＊＊, P<0.001 1 
versus Cont.miR). 2 
 3 
Figure. 5 miR-27a targets TR1. Assays were performed 72 h after transduction into 4 
NRVMs in serum-free conditions. TR1 mRNA and protein levels were detected by 5 
qRT-PCR (A) and immunoblotting (B and C), respectively. A total of 10 g of protein was 6 
used for immunoblotting. D and E, MHC (D and E), RXR (D) and TR1 (E) protein 7 
were detected by immunoblotting in NRVMs transduced with RXR (D) or TR1 siRNAs 8 
(E) in serum-containing conditions. A total of 2 g of protein was used for immunoblotting. 9 
In A, data are presented as mean ± S.E. of three independent experiments In B through E, 10 
data are representative of three independent experiments.     11 
 12 
Figure. 6 Over-expression of miR-27a attenuates thyroid hormone effect. Treatment with 13 
10 nM T3 was started 24 h after transduction and continued for 48 h. A though C, A total 14 
of 2 g of protein was used for immunoblotting of MHC in NRVMs transduced with 15 
miR-27a (A), TR1 siRNAs (B) or RXR siRNAs (C). Data are representative of three 16 
independent experiments. 17 
 18 
Figure. 7 miR-27a regulates -MHC protein expression via TR1. A though C, Treatment 19 
with 10 nM T3 was started 24 h after transduction and continued for 48 h. A total of 2 g of 20 
protein was used for immunoblotting of MHC (A and C) and 10 g of protein for TR1 (B). 21 
 30 
Data are representative of three independent experiments. D, The luciferase construct 1 
contained the 333-bp sequence upstream of the translation initiation site of rat -MHC. 2 
293FT cells were transfected with the luciferase construct and an expression plasmid for rat 3 
TR1 or an empty plasmid with or without 10 nM T3. T3 treatment was started 24 h after 4 
transfection, followed by assays 24 h after treatment. The bar graph indicates values 5 
expressed as relative luciferase activity compared with that for an empty plasmid without 6 
T3 treatment. E, -MHC mRNA was detected by qRT-PCR in NRVMs transduced with 7 
TR1 or empty vector using a lentiviral vector with or without 10 nM T3. T3 treatment was 8 
started 24 h after transduction, followed by RNA extraction 72 h after treatment. Data are 9 


































































































































































































































































































































































































































































































































Rat TRβ1  3’UTR 1291-1800
3’ - CGCCUUGAA-----UCGGUGACACUU - 5’








Human THRAP1  3’UTR 2491-2980
















































Dog UCCACAGUCCUGCACUGUGAU  
Chimpanzee UCCACAGUCCUGCACUGUGAU 
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Human TRβ1  3’UTR 3331-3960
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